Resultados da pesquisa - Lawrence Schwartz
- A mostrar 1 - 10 resultados de 10
-
1
-
2
-
3
-
4
Implementation strategy of a CNN model affects the performance of CT assessment of EGFR mutation status in lung cancer patients Por Xiong, Junfeng, Li, Xiaoyang, Lu, Lin, Lawrence, Schwartz H, Fu, Xiaolong, Zhao, Jun, Zhao, Binsheng
Publicado em 2019Text -
5
-
6
Phase 1 Study of Aflibercept Administered Subcutaneously to Patients with Advanced Solid Tumors Por William P. Tew, Michael S. Gordon, John R. Murren, Jakob Dupont, S. Pezzulli, Carol Aghajanian, Paul Sabbatini, David S. Mendelson, Lawrence Schwartz, Scott Gettinger, Amanda Psyrri, Jesse M. Cedarbaum, David R. Spriggs
Publicado em 2009Artigo -
7
High‐dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma Por Michael J. Morris, Òren Smaletz, David B. Solit, William Kevin Kelly, Susan F. Slovin, Carlos D. Flombaum, Tracy Curley, A. Delacruz, Lawrence Schwartz, Martin Fleisher, Andrew X. Zhu, Meghan Diani, Mary Anne Fallon, Howard I. Scher
Publicado em 2004Artigo -
8
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma Por Jennifer E. Amengual, Renee Lichtenstein, Jennifer Kimberly Lue, Ahmed Sawas, Changchun Deng, Emily Lichtenstein, Karen Khan, Laine E. Atkins, Aishling M. Rada, Hye A. Kim, Codruța Chiuzan, Matko Kalac, Enrica Marchi, Lorenzo Falchi, Mark A. Francescone, Lawrence Schwartz, Serge Cremers, Owen A. O’Connor
Publicado em 2017Artigo -
9
Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting Por Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Jacques Belghiti, Steven A. Curley, Yuman Fong, Gregory J. Gores, Robert K. Kerlan, P. Merle, Bert H. O’Neil, Ronnie T.P. Poon, Lawrence Schwartz, Joel E. Tepper, Francis Y. Yao, Daniel G. Haller, Margaret Mooney, Alan P. Venook
Publicado em 2010Artigo -
10
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC Por Elise A. Olsen, Sean Whittaker, Rein Willemze, Lauren Pinter‐Brown, Francine M. Foss, Larisa J. Geskin, Lawrence Schwartz, Sarah McCue Horwitz, Joan Guitart, John A. Zic, Youn H. Kim, Gary S. Wood, Madeleine Duvic, Wei Ai, Michael Girardi, Alejandro A. Gru, Emmanuella Guenova, Emmilia Hodak, Richard T. Hoppe, Werner Kempf, Ellen Kim, Mary Jo Lechowicz, Pablo L. Ortiz‐Romero, Evangelia Papadavid, Pietro Quaglino, Mark R. Pittelkow, H. Miles Prince, José Antônio Sanches, Makoto Sugaya, Maarten H. Vermeer, Jasmine M. Zain, Robert Knobler, Rudolf Stadler, M. Bagot, Julia Scarisbrick
Publicado em 2021Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Internal medicine
Chemotherapy
Gastroenterology
Oncology
Clinical trial
Disease
Immunology
Lymphoma
Phases of clinical research
Progressive disease
Toxicity
Urology
Adrenocorticotropic hormone
Adverse effect
Aflibercept
Anemia
Antibody
Archaeology
Art history
Astrobiology
Bevacizumab
Biochemistry
Biology
Bortezomib
Calcitriol
Cancer
Chemistry
Chronic lymphocytic leukemia
Cirrhosis